You never know Anders, once you have a lot more to play with chasing the big ticket biotechs might not be such an issue considering the payoffs. Hoping all of us have the luxury of being much more flexible with future portfolios. This board has been an addiction long enough, looking forward to the next addiction whatever that may be.
News 
Market Data 
Discover 
